tiprankstipranks
Trending News
More News >
Blum Holdings (BLMH)
OTHER OTC:BLMH
Advertisement

Blum Holdings (BLMH) AI Stock Analysis

Compare
723 Followers

Top Page

BL

Blum Holdings

(OTC:BLMH)

Rating:50Neutral
Price Target:
$0.50
▼(-13.79%Downside)
The most significant factors affecting Blum Holdings' stock score are its challenging financial position and technical analysis indicators suggesting a bearish trend. However, recent strategic acquisitions and agreements provide positive momentum, potentially enhancing its market position and stabilizing operations.

Blum Holdings (BLMH) vs. SPDR S&P 500 ETF (SPY)

Blum Holdings Business Overview & Revenue Model

Company DescriptionBlum Holdings (BLMH) is a diversified conglomerate operating across multiple sectors including technology, healthcare, and renewable energy. The company is committed to innovation and sustainability, offering a range of products and services designed to improve efficiency and promote environmental stewardship. Blum Holdings' core offerings include advanced software solutions, medical devices, and solar energy systems.
How the Company Makes MoneyBlum Holdings generates revenue through a diversified portfolio of business units. In the technology sector, it earns money by developing and licensing software solutions to enterprise clients, which include proprietary platforms and cloud-based services. In healthcare, the company makes money through the sale and distribution of medical devices, often facilitated by partnerships with hospitals and healthcare providers. Additionally, Blum Holdings capitalizes on the growing demand for renewable energy by manufacturing and installing solar panels and energy storage systems, often working in collaboration with government bodies and private enterprises to deploy large-scale solar projects. Key factors contributing to its earnings include strategic partnerships, a strong focus on research and development, and a commitment to sustainability that aligns with global environmental initiatives.

Blum Holdings Financial Statement Overview

Summary
Blum Holdings faces significant financial challenges, including high leverage and negative stockholders' equity, indicating financial distress. Despite slight improvements in net income and cash flow, the overall financial position remains precarious, necessitating strategic changes for long-term stability.
Income Statement
45
Neutral
The income statement reveals mixed performance. The TTM data shows improvement in net income, but with negative EBIT, indicating potential operational inefficiencies. Gross profit margin has been relatively stable, but the overall revenue trend is declining, which is concerning for growth prospects.
Balance Sheet
30
Negative
The balance sheet shows high leverage with negative stockholders' equity, indicating financial distress. The debt-to-equity ratio is undefined due to negative equity, and the equity ratio is concerning. This suggests potential solvency issues and a need for capital restructuring.
Cash Flow
40
Negative
Cash flow analysis indicates negative free cash flow and operating cash flow, raising concerns about liquidity. However, the TTM shows some improvement in free cash flow compared to previous periods, indicating a potential positive trajectory in cash management.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue12.99M33.23M52.02M42.12M6.16M
Gross Profit6.21M14.00M16.90M11.02M2.64M
EBITDA22.00M-2.26M-171.57M-30.07M-1.83M
Net Income33.10M-14.13M-188.93M-31.27M-30.12M
Balance Sheet
Total Assets24.82M32.07M40.51M271.82M100.29M
Cash, Cash Equivalents and Short-Term Investments1.04M862.00K1.20M6.70M34.26M
Total Debt4.79M37.70M49.56M79.41M23.13M
Total Liabilities29.56M77.77M77.05M125.34M41.16M
Stockholders Equity-4.74M-45.70M-36.54M142.63M54.67M
Cash Flow
Free Cash Flow-2.15M-1.29M-9.76M-21.93M-16.31M
Operating Cash Flow-2.14M-965.00K-7.83M-17.96M-14.84M
Investing Cash Flow2.03M462.00K19.61M21.67M11.80M
Financing Cash Flow143.00K539.00K-17.27M4.50M2.70M

Blum Holdings Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.58
Price Trends
50DMA
0.69
Negative
100DMA
0.77
Negative
200DMA
0.67
Negative
Market Momentum
MACD
-0.03
Positive
RSI
38.77
Neutral
STOCH
58.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLMH, the sentiment is Negative. The current price of 0.58 is below the 20-day moving average (MA) of 0.63, below the 50-day MA of 0.69, and below the 200-day MA of 0.67, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 38.77 is Neutral, neither overbought nor oversold. The STOCH value of 58.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BLMH.

Blum Holdings Risk Analysis

Blum Holdings disclosed 56 risk factors in its most recent earnings report. Blum Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Blum Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
$10.43M0.85-499.57%-33.92%
52
Neutral
$7.35B-0.07-63.71%2.36%16.17%0.03%
50
Neutral
$7.93M0.43-27.37%-56.27%
48
Neutral
$11.78M-117.16%175.03%55.34%
43
Neutral
$14.00M-336.65%-28.78%86.97%
40
Underperform
$9.88M-64.18%1.00%
34
Underperform
$13.92M2.41>-0.01%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BLMH
Blum Holdings
0.58
0.10
20.83%
NERV
Minerva Neurosciences
1.99
-1.24
-38.39%
PAVM
PAVmed
0.60
-0.44
-42.31%
BRTX
BioRestorative Therapies
1.57
-0.14
-8.19%
SNSE
Sensei Biotherapeutics
7.84
-5.54
-41.41%
FLGC
Flora Growth
0.62
-0.52
-45.61%

Blum Holdings Corporate Events

M&A TransactionsBusiness Operations and Strategy
Blum Holdings Acquires Majority Interest in Cannabis Retail
Positive
Jul 3, 2025

On July 1, 2025, Blüm Holdings entered into a binding term sheet to acquire a majority interest in a Northern California cannabis retail operator. The transaction, valued at $5 million, is structured as an all-stock deal with performance-based earn-outs. Through a Management Services Agreement, Blüm has gained operational control of the target’s business, consolidating its operations into Blüm’s financial statements. This acquisition is part of Blüm’s strategy to expand its retail platform and strengthen its market position in California, with the transaction expected to close in Q3 2025.

M&A TransactionsBusiness Operations and Strategy
Blum Holdings Announces Acquisition of Cannabis Brand Stake
Positive
May 21, 2025

On May 15, 2025, Blum Management Holdings, a subsidiary of Blüm Holdings, entered into a Management Service Agreement with a licensed cannabis retail operator in the Bay Area, granting it exclusive operational control while the Target retains the license. This agreement allows Blüm to consolidate the Target’s operations into its financial statements, enhancing its control over operations and financial outcomes. Additionally, on May 21, 2025, Blüm Holdings announced a binding term sheet to acquire a holding company with an equity interest in Cookies, a leading cannabis brand. This strategic move is part of Blüm’s long-term strategy to increase its economic exposure to major cannabis brands, with the transaction expected to close in Q3 2025.

M&A Transactions
Blum Holdings Announces Share Exchange Agreement
Neutral
May 16, 2025

On May 12, 2025, Blum Holdings, Inc. announced its intention to acquire 100% of the membership interests in a holding company with equity in Cookies Creative Consulting & Promotions, Inc. through a Share Exchange Agreement. The transaction will involve issuing shares and warrants valued at $562,500, subject to customary conditions and approvals, although completion is not guaranteed.

M&A TransactionsBusiness Operations and Strategy
Blum Holdings Announces Major Acquisition in California
Positive
May 15, 2025

On May 15, 2025, Blüm Holdings announced the execution of an Amended and Restated Binding Letter of Intent to acquire a licensed retail cannabis operator in Northern California. This acquisition is expected to more than double Blüm’s annual revenue, significantly enhancing its market position in California’s cannabis industry. The transaction involves a total consideration of $2.0 million, structured with cash and common stock, and includes performance-based earn-outs to align with Blüm’s growth objectives. This strategic move is part of Blüm’s plan to become a dominant brand in the California cannabis market.

Executive/Board ChangesM&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Blum Holdings Acquires Bay Area Cannabis Operator
Positive
May 14, 2025

On May 13, 2025, Blüm Holdings executed an Amended and Restated Binding Letter of Intent to acquire a licensed retail cannabis operator in the Bay Area for $2.0 million, gaining immediate operational control. The company also appointed Brad Hirsch to its Board of Directors on May 8, 2025, and reported significant financial improvements for Q1 2025, including a 26% revenue increase and positive EBITDA, reflecting operational efficiency and strategic restructuring.

Private Placements and Financing
Blum Holdings Executes $1M Unsecured Promissory Note
Neutral
May 7, 2025

On May 2, 2025, Blum Holdings, Inc. executed an Unsecured Promissory Note worth $1,000,000 with a maturity date of May 2, 2027, and an interest rate of 8% per annum. This financial move allows the lender to convert the note into shares at a discounted rate and includes warrants for purchasing additional shares, potentially impacting Blum’s capital structure and investor relations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 04, 2025